Eduardo Pennella

Eduardo Pennella has a strong background in the pharmaceutical industry, with a focus on medical leadership and clinical development. Eduardo has held various roles at different companies throughout their career. Some notable positions include serving as the Medical Lead for Petosemtamab at Merus N.V., Vice President Medical at Aravive, Inc., and Executive Director of Clinical Development at MaxCyte, Inc. Prior to that, they worked as a Senior Medical Director at Mylan and as a Medical Advisor at Lilly Oncology and the Pharmaceutical Industry. Eduardo also has experience as a Clinical Research Physician at Eli Lilly and as an Oncology and Critical Care Business Unit Manager at Eli Lilly Southern Cone. Eduardo'searly career includes working as a Medical Manager at Pharmacia & Upjohn and as an Oncologist at Sanatorio Guemes.

Eduardo Pennella obtained their MD degree in Medicine from the University of Buenos Aires, where they studied from 1976 to 1982. Eduardo later pursued further education and earned a degree in Medical Oncology from Universidad Catolica Argentina between 1989 and 1991. Additionally, they completed an MBA program in Business at Universidad de Palermo from 1999 to 2001.